Hair thinning is a side effect that some people experience while taking GLP-1 medications like semaglutide or tirzepatide
For individuals taking glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy) and dulaglutide (Trulicity), or the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound), maintaining adequate magnesium status may be particularly important
This is called sudden sensorineural hearing loss (SSNHL)
Food & Drug Administration (FDA) approved the first GLP-1, exenatide, for treatment of type 2 diabetes
Y., van der Merwe J., Pepe S., Bailey M., Perkins A., Lymbury R., Esmore D., Marasco S., Rosenfeldt F
Pure Encapsulations was built with the purest of hearts and a plan to improve the wellness and wellbeing of others